Form 4: USANA CIO Peter Benedict Exercises RSUs, Sells Shares for Tax

Sentiment:

Insider Transaction Report


USANA Health Sciences Chief Information Officer Peter Benedict reported the exercise of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

  • Peter Benedict, Chief Information Officer of USANA Health Sciences Inc. (USNA), reported multiple transactions involving company common stock.
  • On February 6, 2026, Benedict acquired 1,000 shares of common stock through the vesting of restricted stock units and subsequently disposed of 347 shares at $21.34 to cover tax liabilities.
  • On February 7, 2026, Benedict acquired 631 shares of common stock from vested restricted stock units and disposed of 219 shares at $21.34 for tax purposes.
  • On February 8, 2026, Benedict acquired 1,157 shares of common stock from vested restricted stock units and disposed of 401 shares at $21.34 for tax purposes.
  • Following these transactions, Benedict's direct beneficial ownership of common stock increased to 1,821 shares.
  • The transactions were made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction related to equity compensation vesting. The officer retained a portion of the shares, which is a neutral to slightly positive signal, but the primary purpose was compensation realization and tax coverage.

Positives

  • The Chief Information Officer exercised restricted stock units, indicating the vesting of previously granted equity compensation.
  • The officer retained a significant portion of the acquired shares, increasing direct beneficial ownership to 1,821 shares.

Negatives

  • A portion of the acquired shares was sold to cover tax liabilities, which is a common practice but represents a reduction in the officer's direct holdings.

Future Outlook

No forward-looking statements or guidance were provided in this transactional filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to equity compensation vesting and tax-related sales, are common across all industries. These transactions typically reflect pre-scheduled events under Rule 10b5-1 plans and do not necessarily indicate a change in management's outlook on the company's future performance, unlike open market purchases or sales.

Comparison to Industry Standards

  • Insider transactions involving the exercise of restricted stock units and subsequent sales for tax withholding are standard practice for executive compensation across publicly traded companies.
  • This aligns with typical equity compensation structures seen in the health and wellness industry, similar to practices at companies like Herbalife Nutrition Ltd. (HLF) or Nu Skin Enterprises, Inc. (NUS), where executives regularly report such transactions as part of their compensation plans.

Related Party Transactions

  • The reported transactions involve Peter Benedict, the Chief Information Officer of USANA Health Sciences, exercising restricted stock units and selling shares. These are considered related party transactions as they involve an executive of the company.

Stakeholder Impact

  • Shareholders: The transactions represent a routine part of executive compensation and do not indicate a significant shift in company strategy or financial health. The sale of shares for tax purposes is a common occurrence and does not necessarily signal a lack of confidence.
  • Employees: The vesting of RSUs demonstrates the company's ongoing equity compensation program for its executives.

Key Dates

DateDescription
02/07/2022Anniversary date for 25% vesting of certain Restricted Stock Units.
02/06/2023Anniversary date for 25% vesting of certain Restricted Stock Units.
02/08/2024Anniversary date for 25% vesting of certain Restricted Stock Units.
02/06/2026Transaction date for acquisition of 1,000 common shares and disposition of 347 common shares.
02/07/2026Transaction date for acquisition of 631 common shares and disposition of 219 common shares.
02/08/2026Transaction date for acquisition of 1,157 common shares and disposition of 401 common shares.
02/10/2026Date the Form 4 was signed by the Attorney-in-Fact.

Recommendation

hold

This Form 4 filing details routine insider transactions related to the vesting of restricted stock units and subsequent tax-related sales by the Chief Information Officer. Such transactions are typically pre-scheduled under Rule 10b5-1 plans and do not provide new material information about the company's operational performance or future prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing. A 'hold' recommendation is appropriate as the filing confirms standard compensation practices without signaling any significant positive or negative developments for the company's stock.

Keywords

USANA Health Sciences, USNA, Peter Benedict, Chief Information Officer, CIO, Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Vesting, Equity Compensation, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.